NCT07749105 Enhancing Cognitive and Work/School Outcomes in First Episode Psychosis Using Cognitive Self-Management Strategies
| NCT ID | NCT07749105 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Boston University Charles River Campus |
| Condition | First Episode Psychosis (FEP) |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-08-10 |
| Primary Completion | 2029-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-08-10 with a primary completion date of 2029-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this pilot cluster randomized trial is to understand if adding a standardized cognitive self-management program, Thinking Skills for Work-Cognitive Self-Management Strategies (CSM) to Coordinated Specialty Care Supported Employment and Education (SEE) programs improves the work and school outcomes of young adults experiencing first episode psychosis. The main questions it aims to answer are: * Does adding the CSM program to usual SEE services lead to improved work and school outcomes, such as ability to find a job or enroll in school, or ability to keep a job or stay in school? * Does adding the CSM program to usual SEE services improve cognition and cognitive self-efficacy? Researchers will recruit six research sites and these will be randomized to either treatment as usual, where they will offer regular SEE services, or the experimental groups, where they will offer regular SEE services plus the CSM program. Participants in both groups will be asked to complete a brief assessment at baseline, 6-months, 12-months, and 18-months. Participants in the experimental group will be asked to participate in the 12-session CSM program in addition to their regular SEE services.
Eligibility Criteria
Inclusion Criteria: 1. currently in their first 18 months of enrollment in the CSC program 2. at least 15 years of age 3. receiving SEE services but not employed or enrolled in school 4. have the desire to work or resume school. Exclusion Criteria: 1\) Young adults who are not fluent in english
Contact & Investigator
Susan R McGurk, PhD
PRINCIPAL INVESTIGATOR
Boston University Center for Psychiatric Rehabilitation
Frequently Asked Questions
Who can join the NCT07749105 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, up to 32 Years, studying First Episode Psychosis (FEP). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07749105 currently recruiting?
Yes, NCT07749105 is actively recruiting participants. Contact the research team at mcgurk@bu.edu for enrollment information.
Where is the NCT07749105 trial being conducted?
This trial is being conducted at Big Spring, United States, Granbury, United States, Laredo, United States, Longview, United States.
Who is sponsoring the NCT07749105 clinical trial?
NCT07749105 is sponsored by Boston University Charles River Campus. The principal investigator is Susan R McGurk, PhD at Boston University Center for Psychiatric Rehabilitation. The trial plans to enroll 60 participants.